30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

OSI Pharmaceuticals LLC (OSIP)

Track

Stock chart
Ticker: OSIP
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Astellas Pharma Inc.
1 purchase — total 367,269,463 USD
Buy 7 Jun 2010
Value US$4,384,125.64 | Price 273.72 | Shares 89,345
Buy 4 Jun 2010
Value US$1,476,235.88 | Price 334.44 | Shares 92,131
Planned sale 1 Mar 2010
Value US$1,611,840.00 | Price 55.20 | Shares 29,200
Planned sale 1 Mar 2010
Value US$1,102,200.00 | Price 55.11 | Shares 20,000
Planned sale 1 Mar 2010
Value US$875,968.80 | Price 55.20 | Shares 15,869
Planned sale 1 Mar 2010
Value US$3,641,220.00 | Price 55.17 | Shares 66,000
Planned sale 1 Mar 2010
Value US$2,393,811.21 | Price 55.37 | Shares 43,233
Planned sale 3 Feb 2009
Value US$82,500.00 | Price 41.25 | Shares 2,000
Planned sale 3 Feb 2009
Value US$140,291.25 | Price 41.25 | Shares 3,401
Planned sale 3 Feb 2009
Value US$420,954.00 | Price 42.10 | Shares 10,000
Planned sale 6 Jan 2009
Value US$1,960.00 | Price 40.00 | Shares 49
Sale 19 Nov 2008
Value US$391,100.00 | Price 39.11 | Shares 10,000
Sale 11 Nov 2008
Value US$138,355.00 | Price 39.53 | Shares 3,500
Planned sale 7 Nov 2008
Value US$47,828.50 | Price 41.59 | Shares 1,150
Planned sale 1 Oct 2008
Value US$121,750.00 | Price 48.70 | Shares 2,500
Planned sale 1 Oct 2008
Value US$56,005.00 | Price 48.70 | Shares 1,150
Planned sale 15 Sep 2008
Value US$86,747.50 | Price 49.57 | Shares 1,750
Planned sale 2 Sep 2008
Value US$189,075.00 | Price 50.42 | Shares 3,750
Planned sale 2 Sep 2008
Value US$57,983.00 | Price 50.42 | Shares 1,150
Planned sale 15 Aug 2008
Value US$39,622.50 | Price 52.83 | Shares 750
Planned sale 15 Aug 2008
Value US$26,415.00 | Price 52.83 | Shares 500
Planned sale 15 Aug 2008
Value US$26,415.00 | Price 52.83 | Shares 500
Planned sale 1 Aug 2008
Value US$196,012.50 | Price 52.27 | Shares 3,750
Planned sale 1 Aug 2008
Value US$60,110.50 | Price 52.27 | Shares 1,150
Sale 1 Aug 2008
Value US$31,230.00 | Price 52.05 | Shares 600
Sale 1 Aug 2008
Value US$15,615.00 | Price 52.05 | Shares 300
Sale 1 Aug 2008
Value US$145,740.00 | Price 52.05 | Shares 2,800
Sale 1 Aug 2008
Value US$5,207.00 | Price 52.07 | Shares 100
Sale 1 Aug 2008
Value US$5,207.00 | Price 52.07 | Shares 100
Sale 1 Aug 2008
Value US$5,207.00 | Price 52.07 | Shares 100
Sale 1 Aug 2008
Value US$5,207.00 | Price 52.07 | Shares 100
Sale 1 Aug 2008
Value US$31,230.00 | Price 52.05 | Shares 600
Sale 1 Aug 2008
Value US$5,205.00 | Price 52.05 | Shares 100
Sale 1 Aug 2008
Value US$10,414.00 | Price 52.07 | Shares 200
Sale 1 Aug 2008
Value US$10,500.00 | Price 52.50 | Shares 200
Sale 1 Aug 2008
Value US$15,615.00 | Price 52.05 | Shares 300
Sale 1 Aug 2008
Value US$114,510.00 | Price 52.05 | Shares 2,200
Sale 1 Aug 2008
Value US$15,615.00 | Price 52.05 | Shares 300
Planned sale 31 Jul 2008
Value US$16,023.00 | Price 53.41 | Shares 300
Planned sale 31 Jul 2008
Value US$16,020.00 | Price 53.40 | Shares 300
Planned sale 31 Jul 2008
Value US$26,645.00 | Price 53.29 | Shares 500
Planned sale 31 Jul 2008
Value US$47,934.00 | Price 53.26 | Shares 900
Planned sale 31 Jul 2008
Value US$58,520.00 | Price 53.20 | Shares 1,100
Planned sale 31 Jul 2008
Value US$28,217.20 | Price 53.24 | Shares 530
Planned sale 31 Jul 2008
Value US$63,864.00 | Price 53.22 | Shares 1,200
Planned sale 31 Jul 2008
Value US$31,926.00 | Price 53.21 | Shares 600
Planned sale 31 Jul 2008
Value US$47,862.00 | Price 53.18 | Shares 900
Planned sale 31 Jul 2008
Value US$15,170.55 | Price 53.23 | Shares 285
Planned sale 31 Jul 2008
Value US$15,176.25 | Price 53.25 | Shares 285
Planned sale 31 Jul 2008
Value US$15,912.00 | Price 53.04 | Shares 300
Planned sale 31 Jul 2008
Value US$31,812.00 | Price 53.02 | Shares 600
Planned sale 31 Jul 2008
Value US$37,100.00 | Price 53.00 | Shares 700
Planned sale 31 Jul 2008
Value US$21,100.00 | Price 52.75 | Shares 400
Planned sale 31 Jul 2008
Value US$26,295.00 | Price 52.59 | Shares 500
Planned sale 31 Jul 2008
Value US$63,444.00 | Price 52.87 | Shares 1,200
Planned sale 31 Jul 2008
Value US$73,500.00 | Price 52.50 | Shares 1,400
Planned sale 31 Jul 2008
Value US$15,759.00 | Price 52.53 | Shares 300
Planned sale 31 Jul 2008
Value US$47,304.00 | Price 52.56 | Shares 900
Planned sale 31 Jul 2008
Value US$15,786.00 | Price 52.62 | Shares 300
Planned sale 31 Jul 2008
Value US$15,816.00 | Price 52.72 | Shares 300
Planned sale 31 Jul 2008
Value US$26,365.00 | Price 52.73 | Shares 500
Planned sale 31 Jul 2008
Value US$15,801.00 | Price 52.67 | Shares 300
Planned sale 31 Jul 2008
Value US$21,008.00 | Price 52.52 | Shares 400
Planned sale 24 Jul 2008
Value US$1,211,403.00 | Price 51.00 | Shares 23,753
Planned sale 24 Jul 2008
Value US$268,006.54 | Price 51.01 | Shares 5,254
Planned sale 24 Jul 2008
Value US$91,872.00 | Price 51.04 | Shares 1,800
Planned sale 24 Jul 2008
Value US$71,442.00 | Price 51.03 | Shares 1,400
Planned sale 24 Jul 2008
Value US$30,612.00 | Price 51.02 | Shares 600
Planned sale 24 Jul 2008
Value US$82,752.05 | Price 51.05 | Shares 1,621
Planned sale 24 Jul 2008
Value US$40,856.00 | Price 51.07 | Shares 800
Planned sale 24 Jul 2008
Value US$167,199.20 | Price 51.10 | Shares 3,272
Planned sale 24 Jul 2008
Value US$265,824.00 | Price 51.12 | Shares 5,200
Planned sale 24 Jul 2008
Value US$24,491.27 | Price 51.13 | Shares 479
Planned sale 24 Jul 2008
Value US$45,999.00 | Price 51.11 | Shares 900
Planned sale 24 Jul 2008
Value US$1,638.40 | Price 51.20 | Shares 32
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2010-06-09 2010-06-07 B Purchase Astellas Pharma Inc. Large shareholder
89,345 -8.7%
273.72
US$4,384,126 		89,345 -8.7% 273.72 US$4,384,126
2010-06-08 2010-06-04 B Purchase Astellas Pharma Inc. Large shareholder
92,131 +13.1%
334.44
US$1,476,236 		92,131 +13.1% 334.44 US$1,476,236
2010-03-03 2010-03-01 PlS Planned sale LUNDEMOSE ANKER MD, PH.D, DSC

EVP, Corp. Dev & Strategic Pln

Officer
99,041 +10.0%
226.14
US$2,041,016 		99,041 +10.0% 226.14 US$2,041,016
2010-03-03 2010-03-01 PlS Planned sale WOOD BARBARA A

Sr. V.P. & General Counsel

Officer
20,000 -42.2%
55.11
US$1,102,200 		20,000 -42.2% 55.11 US$1,102,200
2010-03-03 2010-03-01 PlS Planned sale AMPER LINDA E

Sr. VP, Human Resources

Officer
15,869 -45.4%
55.20
US$875,969 		15,869 -45.4% 55.20 US$875,969
2010-03-03 2010-03-01 PlS Planned sale GODDARD COLIN

Chief Executive Officer

Executive Director
66,000 -29.4%
55.17
US$3,641,220 		66,000 -29.4% 55.17 US$3,641,220
2010-03-03 2010-03-01 PlS Planned sale LEUNG GABRIEL

EVP & Pres. Pharma. Business

Officer
43,233 -53.0%
55.37
US$2,393,811 		43,233 -53.0% 55.37 US$2,393,811
2009-02-05 2009-02-03 PlS Planned sale LUNDEMOSE ANKER MD, PH.D, DSC

Exec. VP & Pres. OSI Prosidion

Officer
2,000 -6.8%
41.25
US$82,500 		2,000 -6.8% 41.25 US$82,500
2009-02-05 2009-02-03 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
3,401 -9.0%
41.25
US$140,291 		3,401 -9.0% 41.25 US$140,291
2009-02-05 2009-02-03 PlS Planned sale GRANNER DARYL K Non-Executive Director
10,000 -37.7%
42.10
US$420,954 		10,000 -37.7% 42.10 US$420,954
2009-01-07 2009-01-06 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
49 -0.1%
40.00
US$1,960 		49 -0.1% 40.00 US$1,960
2008-11-21 2008-11-19 S Sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
10,000 -23.1%
39.11
US$391,100 		10,000 -23.1% 39.11 US$391,100
2008-11-12 2008-11-11 S Sale LUNDEMOSE ANKER MD, PH.D, DSC

Exec. VP & Pres. OSI Prosidion

Officer
3,500 -14.0%
39.53
US$138,355 		3,500 -14.0% 39.53 US$138,355
2008-11-12 2008-11-07 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
1,150 -4.4%
41.59
US$47,828 		1,150 -4.4% 41.59 US$47,828
2008-10-02 2008-10-01 PlS Planned sale GRANNER DARYL K Non-Executive Director
2,500 -13.1%
48.70
US$121,750 		2,500 -13.1% 48.70 US$121,750
2008-10-02 2008-10-01 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
1,150 -3.6%
48.70
US$56,005 		1,150 -3.6% 48.70 US$56,005
2008-09-16 2008-09-15 PlS Planned sale WHITE JOHN P Non-Executive Director
1,750 -7.9%
49.57
US$86,748 		1,750 -7.9% 49.57 US$86,748
2008-09-04 2008-09-02 PlS Planned sale GRANNER DARYL K Non-Executive Director
3,750 -18.5%
50.42
US$189,075 		3,750 -18.5% 50.42 US$189,075
2008-09-04 2008-09-02 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
1,150 -3.7%
50.42
US$57,983 		1,150 -3.7% 50.42 US$57,983
2008-08-19 2008-08-15 PlS Planned sale WHITE JOHN P Non-Executive Director
750 -3.4%
52.83
US$39,622 		750 -3.4% 52.83 US$39,622
2008-08-19 2008-08-15 PlS Planned sale WHITE JOHN P Non-Executive Director
500 -2.2%
52.83
US$26,415 		500 -2.2% 52.83 US$26,415
2008-08-19 2008-08-15 PlS Planned sale WHITE JOHN P Non-Executive Director
500 -2.2%
52.83
US$26,415 		500 -2.2% 52.83 US$26,415
2008-08-05 2008-08-01 PlS Planned sale GRANNER DARYL K Non-Executive Director
3,750 -22.7%
52.27
US$196,012 		3,750 -22.7% 52.27 US$196,012
2008-08-05 2008-08-01 PlS Planned sale SIMON ROBERT L

Exec. VP, Pharm. Dev. & Manf.

Officer
1,150 -3.7%
52.27
US$60,110 		1,150 -3.7% 52.27 US$60,110
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
600 -100.0%
52.05
US$31,230 		600 -100.0% 52.05 US$31,230
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
300 -33.3%
52.05
US$15,615 		300 -33.3% 52.05 US$15,615
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
2,800 -75.7%
52.05
US$145,740 		2,800 -75.7% 52.05 US$145,740
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
100 -2.6%
52.07
US$5,207 		100 -2.6% 52.07 US$5,207
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
100 -2.6%
52.07
US$5,207 		100 -2.6% 52.07 US$5,207
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
100 -2.5%
52.07
US$5,207 		100 -2.5% 52.07 US$5,207
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
100 -2.4%
52.07
US$5,207 		100 -2.4% 52.07 US$5,207
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
600 -12.8%
52.05
US$31,230 		600 -12.8% 52.05 US$31,230
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
100 -2.1%
52.05
US$5,205 		100 -2.1% 52.05 US$5,205
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
200 -4.0%
52.07
US$10,414 		200 -4.0% 52.07 US$10,414
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
200 -1.7%
52.50
US$10,500 		200 -1.7% 52.50 US$10,500
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
300 -2.5%
52.05
US$15,615 		300 -2.5% 52.05 US$15,615
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
2,200 -15.5%
52.05
US$114,510 		2,200 -15.5% 52.05 US$114,510
2008-08-01 2008-08-01 S Sale KLEIN JOSEPH III Non-Executive Director
300 -2.1%
52.05
US$15,615 		300 -2.1% 52.05 US$15,615
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
300 -1.1%
53.41
US$16,023 		300 -1.1% 53.41 US$16,023
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
300 -1.0%
53.40
US$16,020 		300 -1.0% 53.40 US$16,020
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
500 -1.7%
53.29
US$26,645 		500 -1.7% 53.29 US$26,645
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
900 -3.0%
53.26
US$47,934 		900 -3.0% 53.26 US$47,934
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
1,100 -3.5%
53.20
US$58,520 		1,100 -3.5% 53.20 US$58,520
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
530 -1.7%
53.24
US$28,217 		530 -1.7% 53.24 US$28,217
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
1,200 -3.6%
53.22
US$63,864 		1,200 -3.6% 53.22 US$63,864
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
600 -1.8%
53.21
US$31,926 		600 -1.8% 53.21 US$31,926
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
900 -2.6%
53.18
US$47,862 		900 -2.6% 53.18 US$47,862
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
285 -0.8%
53.23
US$15,171 		285 -0.8% 53.23 US$15,171
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
285 -0.8%
53.25
US$15,176 		285 -0.8% 53.25 US$15,176
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
300 -0.8%
53.04
US$15,912 		300 -0.8% 53.04 US$15,912
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
600 -1.7%
53.02
US$31,812 		600 -1.7% 53.02 US$31,812
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
700 -1.9%
53.00
US$37,100 		700 -1.9% 53.00 US$37,100
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
400 -1.1%
52.75
US$21,100 		400 -1.1% 52.75 US$21,100
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
500 -1.3%
52.59
US$26,295 		500 -1.3% 52.59 US$26,295
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
1,200 -3.1%
52.87
US$63,444 		1,200 -3.1% 52.87 US$63,444
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
1,400 -3.5%
52.50
US$73,500 		1,400 -3.5% 52.50 US$73,500
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
300 -0.7%
52.53
US$15,759 		300 -0.7% 52.53 US$15,759
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
900 -2.2%
52.56
US$47,304 		900 -2.2% 52.56 US$47,304
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
300 -0.7%
52.62
US$15,786 		300 -0.7% 52.62 US$15,786
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
300 -0.7%
52.72
US$15,816 		300 -0.7% 52.72 US$15,816
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
500 -1.2%
52.73
US$26,365 		500 -1.2% 52.73 US$26,365
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
300 -0.7%
52.67
US$15,801 		300 -0.7% 52.67 US$15,801
2008-08-01 2008-07-31 PlS Planned sale LEUNG GABRIEL

Exec. VP, Pres., (OSI) Onc.

Officer
400 -0.9%
52.52
US$21,008 		400 -0.9% 52.52 US$21,008
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
23,753 -35.4%
51.00
US$1,211,403 		23,753 -35.4% 51.00 US$1,211,403
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
5,254 -7.3%
51.01
US$268,007 		5,254 -7.3% 51.01 US$268,007
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
1,800 -2.4%
51.04
US$91,872 		1,800 -2.4% 51.04 US$91,872
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
1,400 -1.9%
51.03
US$71,442 		1,400 -1.9% 51.03 US$71,442
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
600 -0.8%
51.02
US$30,612 		600 -0.8% 51.02 US$30,612
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
1,621 -2.1%
51.05
US$82,752 		1,621 -2.1% 51.05 US$82,752
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
800 -1.0%
51.07
US$40,856 		800 -1.0% 51.07 US$40,856
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
3,272 -4.0%
51.10
US$167,199 		3,272 -4.0% 51.10 US$167,199
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
5,200 -6.0%
51.12
US$265,824 		5,200 -6.0% 51.12 US$265,824
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
479 -0.5%
51.13
US$24,491 		479 -0.5% 51.13 US$24,491
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
900 -1.0%
51.11
US$45,999 		900 -1.0% 51.11 US$45,999
2008-07-28 2008-07-24 PlS Planned sale ATIEH MICHAEL G

Exec. VP & CFO

Officer
32 -0.0%
51.20
US$1,638 		32 -0.0% 51.20 US$1,638
Explore more

More insider trading research around OSI Pharmaceuticals LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America